Tadalista 20 mg is handled at multiple levels: Regulatory Authorities – In most countries, agencies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) oversee the safety of prescription medications. They collect reports of side effects, review safety data, and can issue warnings or update labels. Manufacturers / Pharmaceutical Companies – The company that produces Tadalista (commonly marketed by Ajanta Pharma in some regions) is legally required to monitor, record, and report adverse events from patients and healthcare providers. This is called pharmacovigilance. Healthcare Professionals – Doctors, pharmacists, and nurses report observed side effects from patients using Tadalista 20 mg to national regulatory systems or the manufacturer. They also counsel patients on recognizing serious adverse effects. Patients / Consumers – Users are encouraged to report unusual or severe side effects to their doctor or through national reporting systems (for example, MedWatch in the U.S.). Patient feedback helps regulators and manufacturers detect rare or serious reactions. Overall, the combination of regulatory agencies, pharmaceutical companies, healthcare professionals, and patient reports ensures continuous monitoring of Tadalista 20 mg’s safety profile.